With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. 

ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. 

Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.

Biotechnology

Health Care

Medical Devices

Pharmaceutical

ARCHIMED

Denis Ribon

Jeppe Lindgaard

David Vay

Edouard Trackoen

Thierry Picard

Florian Demleitner

André-Michel Ballester

The Investment Management team at ARCHIMED is responsible for sourcing, evaluating, and executing investment opportunities within the healthcare sector. With a strong focus on strategic partnerships and impact investing, the team collaborates closely with portfolio companies to drive growth, internationalization, and innovation. They leverage their extensive expertise to manage a diverse portfolio of funds, ensuring alignment with ARCHIMED's mission to support transformative healthcare solutions.

Investment Management

Human Resources

Leadership Team

Investment Management

About

Team members

Other teams at ARCHIMED

Human Resources

Leadership Team